Author correction to “Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors” [Acta Pharmaceutica Sinica B 12 (2022) 4501–4518]

Benzer Materyaller

• Author correction to “Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry” [Acta Pharmaceutica Sinica B 10 (2020) 789–798]
  Yazar:: Ke Tang, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-07-01)
• Author correction to “Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors” [Acta Pharmaceutica Sinica B 12 (2022) 4501–4518]
  Yazar:: Yuling Mao, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-03-01)
• Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
  Yazar:: Tingting Jiang, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-06-01)
• Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
  Yazar:: Canhao Wu, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-11-01)
• Publisher erratum to “Fenofibrate-promoted hepatomegaly and liver regeneration are PPARα-dependent and partially related to the YAP pathway” [Acta Pharmaceutica Sinica B 14 (2024) 2992–3008]
  Yazar:: Shicheng Fan, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-06-01)